Concepedia

Felix Bock

FB

Statistics

Publications

60

Citations

3.5K

H-Index

36

Active since

1973

Affiliations

University of Cologne(Current)

Friedrich-Alexander-Universität Erlangen-Nürnberg

University Hospital Cologne

Universitätsklinikum Erlangen

Harvard University

Felix Bock is an author at University of Cologne specializing in medicine, ophthalmology, and immunology.

ORCID

Top concepts

Publications per year

1973–2023

60

Publications

60

Bevacizumab as a Potent Inhibitor of Inflammatory Corneal Angiogenesis and Lymphangiogenesis

Felix Bock, Jasmine Onderka, Tina Dietrich-Ntoukas et al. · Investigative Ophthalmology & Visual Science · 2007 · 319 citations · Full text

Cutting Edge: Lymphatic Vessels, Not Blood Vessels, Primarily Mediate Immune Rejections After Transplantation

Tina Dietrich-Ntoukas, Felix Bock, Don Yuen et al. · The Journal of Immunology · 2009 · 280 citations · Full text

, , +20

Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin®) eye drops against corneal neovascularization

Y. Koenig, Felix Bock, Folkert K. Horn et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2009 · 177 citations

, , +7

Bevacizumab (Avastin) eye drops inhibit corneal neovascularization

Felix Bock, Y. König, Friedrich E. Kruse et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2007 · 172 citations

, , +6

Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes

Claus Cursiefen, Kazuichi Maruyama, Felix Bock et al. · The Journal of Experimental Medicine · 2011 · 160 citations · Full text

1–5 of 60